TerminatedNot Applicable

BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden

Stopped: Due to Corona/Covid19 pandemic

Sweden19 participantsStarted 2019-04-11

Plain-language summary

Primary objective of the study is to establish the incidence of all any catheter related complications in BIP CVC and standard CVC groups in patients requiring CVC. (CVC - Central Venous Catheter; BIP - Bactiguard Infection Protection)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients admitted to the Access Center at Danderyd who need an elective CVC (surgery, infection, nutrition, medication…)
✓. Fully recognize and understand patient information
✓. Signed informed consent

Exclusion criteria

✕. If CVC present prior to inclusion in the study and no intention to change the present CVC over guidewire
✕. Age \< 18 years
✕. Pregnant women
✕. Known allergy to gold, silver and palladium
✕. Participation in other clinical studies which may interfere with this study as judged by the Investigator

What they're measuring

Number of patients with catheter related complications

Timeframe: From CVC insertion until CVC withdrawal

Trial details

NCT IDNCT03976557

SponsorBactiguard AB

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-12-18

View on ClinicalTrials.gov More Vascular Access Complication trials